• Biosimilars, Biotherapeutics, mRNA Vaccines

    Driven by strong R&D as well as manufacturing capability, we believe in accelerating drug development for the world. We offer a state-of-the art platform for the development of biosimilars, biotherapeutics and mRNA Vaccines using E.coli as host system.

Item 1 of 2

Our Mission

Our mission is to develop into an integrated biotechnology company that transforms its R&D endeavours into cost effective healthcare products of highest quality to serve the economically challenged patients across the world.We aim to become a leader in developing and manufacturing of niche therapeutic bio-similars in the market segments such as Oncology, Diabetics & Osteoporosis products while creating value for all stakeholders.